Nuwellis, Inc. filed a Certificate of Amendment with the State of Delaware to effect a one-for-nine reverse stock split of its common stock. The split became effective at 5:00 p.m. Eastern Time on October 26, 2026, with adjusted trading beginning on October 27, 2026. Fractional shares resulting from the conversion will be rounded down to whole shares, with cash paid for any remaining fractions based on the closing price on the last trading day prior to effectiveness. Proportionate adjustments were made to outstanding options, warrants, and preferred stock exercise prices. Nuwellis develops medical devices for hemodialysis and renal care.
